Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/8705
ACE2 polymorphisms as potential players in COVID-19 outcome
André Salim Khayat
paulo assumpcao
Bruna Khayat
Taíssa Maíra Araújo
Jessica Batista-Gomes
LUCIANA IMBIRIBA
Geraldo Ishak
Paula Assumpção
Fabiano Moreira
Rommel Burbano
Andre M Ribeiro-dos-Santos
Ândrea Ribeiro_dos_Santos
Ney Pereira Carneiro dos Santos
Sidney Santos
Acceso Abierto
Atribución-NoComercial-SinDerivadas
https://doi.org/10.1101/2020.05.27.20114843
https://www.medrxiv.org/content/10.1101/2020.05.27.20114843v1
The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, ACE2 polymorphisms should influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.
bioRxiv
29-05-2020
Preimpreso
Inglés
Público en general
VIRUS RESPIRATORIOS
Aparece en las colecciones: Materiales de Consulta y Comunicados Técnicos

Cargar archivos: